The Luxembourg Anti-Doping Agency (ALAD) has announced that, following the F91 Dudelange - CS Fola Esch championship match on 14 May 2017, the analysis of the urine sample by footballer Emmanuel Françoise resulted in a positive result due to the presence of terbutaline.

The specified substance is listed in Section S.3 Beta-2-Agonists of the World Anti-Doping Agency's (WADA) list of banned substances and methods that are prohibited at all times.

This constitutes an anti-doping rule violation under Article 2.1 (presence of a Prohibited Substance, its metabolites or markers in a sample provided by an Athlete) of the Code of the Luxembourg Anti-Doping Agency. By letter dated 19 June 2017, ALAD applied to the Disciplinary Committee against Doping (CDD) to determine and decide on the alleged violation of the anti-doping rule committed by Emmanuel Françoise.

At the hearing scheduled for 6 July 2017, Emmanuel Françoise did not challenge the alleged facts.

By declaring the proceedings to be lawful and finding, on the basis of the circumstances of the case, that the player had not committed any material fault, the CDD pronounced the sanction of a reprimand without suspension.

The decision may be appealed to the Higher Disciplinary Council against Doping, which must be appealed within fourteen days.

Emmanuel Françoise, originally from Metz in France, played for CS Fola for 3 seasons and transferred to Progrès Niederkorn on 1 July; in the UEFA Europa League first qualifying round, he scored one of the two gols to sensationally knock Glasgow Rangers out of the competition. See http://www.chronicle.lu/categoriessportfootball/item/22517-progrès-niederkorn-sensationally-dump-glasgow-rangers-out-of-europe